Gloria J. Basse's most recent trade in Immucell Corp. was a trade of 11,470 Non Qualified Stock Options (Right to buy) done . Disclosure was reported to the exchange on June 11, 2025.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Immucell Corp | Gloria J. Basse | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Jun 2025 | 11,470 | 3,530 | - | - | Non Qualified Stock Options (Right to buy) | |
Immucell Corp | Gloria J. Basse | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.81 per share. | 11 Jun 2025 | 3,530 | 3,530 (0%) | 0% | 4.8 | 16,979 | Common stock $0.10 per value per share |
Immucell Corp | Gloria J. Basse | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Jun 2025 | 3 | 0 | - | - | Non Qualified Stock Options (Right to buy) | |
Immucell Corp | Gloria J. Basse | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Sep 2024 | 10,000 | 10,000 | - | - | Non Qualified Stock Options (Right to buy) | |
Immucell Corp | Gloria J. Basse | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Dec 2022 | 10,000 | 10,000 | - | - | Non Qualified Stock Options (Right to buy) | |
Immucell Corp | Gloria J. Basse | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jun 2021 | 15,000 | 15,000 | - | - | Incentive Stock Options (Right to buy) | |
Immucell Corp | Gloria J. Basse | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jun 2021 | 10,000 | 10,000 | - | - | Incentive Stock Options (Right to buy) |